Descubra las mejores clínicas y precios de Cardiología en Emiratos Árabes Unidos 2024

Dr. Tamkeen Kinah is a Consultant Cardiologist, Clinical and Preventive Cardiology. He is the Head of the Cardiology and Internal Medicine Departments at Dubai London Hospital. Dr. Kinah is a Clinical Professor at Baylor University, Texas, USA, Adjunct Professor at Lincoln American University, South America and Adjunct Clinical Associate Professor at the University of Sharjah, School of Medicine.He received his Ph.D. qualification (Candidate of Medical Sciences) in Cardiology from the Russian Federation. He has done extensive research in atrial fibrillation and cardiovascular diseases, and many of his articles have been published in leading journals across the country.Dr. Kinah also received a Post-Graduate Diploma in Preventive Cardiovascular Medicine from the United Kingdom with distinction and holds a Level 2 Certification from the University of California in Cardiac CT Angiography. Dr Kinah is also GCAA designated specialist aeromedical examiner.Languages: English, Russian, Urdu

El Dr. Kaaka ha completado su educación médica y su formación especializada en instituciones reconocidas, demostrando su experiencia en medicina interna y cardiología. Su pertenencia a importantes asociaciones médicas pone de manifiesto su compromiso con su campo. Formación académica Doctor en Medicina (M.D), Universidad de Damasco, 1994 Especialista en Medicina Interna, Hospital Central de Damasco, Ministerio de Sanidad, 2000 Especialista en Cardiología, Instituto del Corazón Al-Basel, Ministerio de Sanidad de Damasco, 2005 Especialista en Medicina Interna en Enfermedades Cardiovasculares, DHA, 2013 Afiliación Asociación Médica Siria Sociedad Médica Siria-Estadounidense de Cardiología (SAMSC) Consejo Europeo de Acreditación en Cardiología (EBAC) Operaciones realizadas Ecocardiografía (ETT transtorácica) ECG + Prueba de esfuerzo (Prueba en cinta rodante) Supervisión C.C.U (Observación y Monitorización) Cateterismo Cardíaco Diagnóstico + Cateterismo Terapéutico (ICP - ACTP) Implantación de Marcapasos Temporal + Permanente

Biography Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy Breast cancer Solid tumor diagnosis Digestive cancer Gynecological cancer Lung cancer Genitourinary cancer Sarcoma Awards & Achievements Award from Himaya Foundations and University of Sharjah Research & Publications Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3. The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6. The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87. Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272. First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21